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In addition to the immediate microenvironment, long-range signaling may be an important
component of cancer. Molecular-genetic analyses have implicated gap junctions—key
mediators of cell-cell communication—in carcinogenesis. We recently showed that the
resting voltage potential of distant cell groups is a key determinant of metastatic
transformation and tumor induction. Here, we show in the Xenopus laevis model that
gap junctional communication (GJC) is a modulator of the long-range bioelectric signaling
that regulates tumor formation. Genetic disruption of GJC taking place within tumors,
within remote host tissues, or between the host and tumors significantly lowers the
incidence of tumors induced by KRAS mutations. The most pronounced suppression
of tumor incidence was observed upon GJC disruption taking place farther away from
oncogene-expressing cells, revealing a role for GJC in distant cells in the control of
tumor growth. In contrast, enhanced GJC communication through the overexpression
of wild-type connexin Cx26 increased tumor incidence. Our data confirm a role for GJC
in tumorigenesis, and reveal that this effect is non-local. Based on these results and on
published data on movement of ions through GJs, we present a quantitative model linking
the GJC coupling and bioelectrical state of cells to the ability of oncogenes to initiate
tumorigenesis. When integrated with data on endogenous bioelectric signaling during
left-right patterning, the model predicts differential tumor incidence outcomes depending
on the spatial configurations of gap junction paths relative to tumor location and major
anatomical body axes. Testing these predictions, we found that the strongest influence of
GJ modulation on tumor suppression by hyperpolarization occurred along the embryonic
left-right axis. Together, these data reveal new, long-range aspects of cancer control by the
host’s physiological parameters.
Keywords: cancer, connexin, ion channel, membrane voltage, bioelectricity, long-range signaling, left-right
asymmetry
INTRODUCTION
Consistent pattern formation during embryogenesis and organ
regeneration requires the coordination of cell activities and infor-
mation across large distances in vivo. Alongside gradients of
extracellular secreted molecules, functions an important sys-
tem of direct cell to cell communication. Gap junctions are
intercellular channels that allow small molecule-mediated sig-
nals to pass directly from the cytoplasm of one cell to its
neighbors (Goodenough et al., 1996; Bruzzone et al., 1996a,b).
Connexins, subunits that make up gap junctions (GJs), control
the transfer of a wide range of cellular molecules based on their
charge, size, and shape (Loewenstein, 1979, 1981; Goldberg et al.,
2004), serving as true electrical synapses among non-neural cells
(Bennett, 1997; Pereda et al., 2013; Rash et al., 2013). Due to
their rich combinatorial properties and gating regulation, gap
junction function can implement complex circuits with prop-
erties such as memory (Palacios-Prado and Bukauskas, 2009;
Pereda et al., 2013). Many biological processes have evolved to
take advantage of these versatile elements, using GJs to regu-
late differentiation, proliferation, and apoptosis (Krysko et al.,
2005; Wong et al., 2008), as well as morphogenetic signaling
in many contexts, including development of the brain, limb,
bone, tooth, heart, and the left-right axis (Levin, 2007; Wong
et al., 2008). Not surprisingly, loss of morphogenetic control
due to defective gap junctional communication (GJC) has been
implicated in numerous disorders, including hearing impair-
ment (Rabionet et al., 2000), neural tube defects (Ewart et al.,
1997), parasitic infection (Vega et al., 2013), cardiovascular dis-
eases (Jongsma and Wilders, 2000), and other genetic syndromes
(Zoidl and Dermietzel, 2010). Interestingly, while GJC is most
often thought of as mediating local interaction, it can also
provide long-range morphogenetic coordination on the scale
of the whole organism, for example during the establishment
of polarity in regenerating planaria (Oviedo et al., 2010) and
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left-right pattering of Xenopus and chick (Levin and Mercola,
1998, 1999).
A major area in which GJC has been implicated is tumorigen-
esis (Yamasaki et al., 1995, 1999; Ruch and Trosko, 2001; Trosko,
2005; King and Bertram, 2005; Mesnil et al., 2005). A role for GJs,
as mediators of cell-cell signaling and information exchange, is
consistent with a view of cancer as a developmental disorder—a
derangement of the interaction of cells with the normally tight
field of patterning controls of the body (Tsonis, 1987; Pierce and
Speers, 1988; Clark, 1995; Dean, 1998; Rubin, 2006; Bissell and
Hines, 2011; Marongiu et al., 2012). Alongside cell-autonomous
mutations in so-called cancer stem cells, tumorigenesis and pro-
gression are controlled by biophysical properties of the surround-
ing microenvironment (Chernet and Levin, 2013a) and even by
neural inputs (Scharrer, 1953; Pawlowski and Weddell, 1967;
Magnon et al., 2013). The molecular nature of the processes by
which surrounding cells regulate transformation and metastasis
is an important area of research today.
By regulating the spread of morphogenetic signals, GJs are an
ideal candidate for keeping individual cell activities coordinated
toward the anatomical needs of the host, or conversely, allowing
confounding signals that may induce tumorigenesis (Levin, 2011,
2012b). Disruption in the function of GJs is implicated in a num-
ber of cancers (Yamasaki et al., 1995; Duflot-Dancer et al., 1997;
Yamasaki et al., 1999; Ruch and Trosko, 2001; Mesnil et al., 2005;
Sirnes et al., 2012). For example, Cx26-deficient mice exhibit a
25-fold increased incidence of spontaneous liver tumors (Temme
et al., 1997). Moreover, tumor incidence is higher, and clinical
prognosis is worse, when cells are gap-junctionally isolated by
pharmacological agents or genetic mutation (Loewenstein and
Kanno, 1966; Loewenstein, 1979; Rose et al., 1993; Mesnil et al.,
2005).
Most clinically-relevant tumor cells are known to exhibit
down-regulation in connexin expression, leading to the disrup-
tion of effective cell:cell communication (Soroceanu et al., 2001;
Gee et al., 2003; Mesnil et al., 2005; Talbot et al., 2013). However,
in some some studies, enhanced GJC was suggested as a tumor
promoting factor (Saito-Katsuragi et al., 2007; Naoi et al., 2007;
Elzarrad et al., 2008; Haass et al., 2010). Breast cancer and
melanoma cells take advantage of these connexins to enhance
their metastatic potential in Stoletov et al. (2013). Together, the
data suggest that it is imperative to understand the signaling
mediated by GJs and the information passed among normal cells
that could promote (Rose and Wallingford, 1948; Lewalle et al.,
1998; Zhang et al., 2003; Donahue et al., 2003), or normalize
(Hendrix et al., 2007), cancer in vivo. How might GJC regulate
tumorigenesis in the context of tissue and organ patterning?
One carrier of the morphogenetic cues that go awry during
tumorigenesis may be current—the movement of charged ions.
Gradients of resting potentials established by ion channels and
pumps in the cell membrane are now known to be instructive
patterning cues that regulate cell behavior during pattern forma-
tion (Levin, 2012a; Tseng and Levin, 2013; Levin, 2013, 2014),
and gap junctions sculpt the distribution of iso-potential cell
fields by allowing specific cells to equalize their trans-membrane
voltages (Vmem) in response to various physiological signals.
Bioelectric gradients have already been implicated in the control
of metastasis (Morokuma et al., 2008; Blackiston et al., 2011)
and oncogene-mediated tumorigenesis (Lobikin et al., 2012;
Chernet and Levin, 2013a,b, 2014), while specific ion channels are
becoming increasingly recognized as oncogenes and important
drug targets (Diss et al., 2005; Fraser et al., 2005; Arcangeli et al.,
2009; House et al., 2010; Yildirim et al., 2012; Arcangeli et al.,
2012; Yang and Brackenbury, 2013; Than et al., 2014; Pardo and
Stuhmer, 2014). Interestingly, the resting potentials of distant cells
are critical for oncogene-dependent tumorigenesis: modulation
of ion channels in locations quite distant to oncogene express-
ing cells in Xenopus tadpoles significantly reduces the incidence
of tumors. This effect is mediated by a butyrate-based mecha-
nism that regulates oncogene-mediated tumorigenesis via histone
deacetylase activity (Chernet and Levin, 2013a,b, 2014), but the
spatial dynamics of butyrate signaling in this context remain to
be elucidated. The known role for ion flows and resting potentials
in cancer suggests the possibility that gap junctions participate
in bioelectric regulation during carcinogenesis and/or neoplastic
progression.
To investigate the complex interplay of physiological and
genetic signals in tumorigenesis, we pursued a combination
of modeling and experiment to probe the spatial relation-
ships between tumorigenesis, voltage properties, and GJ paths
in vivo. We recently showed that ion channel-mediated changes
in Vmem can modulate the tumorigenicity of human onco-
genes misexpressed in the Xenopus laevis embryo (Chernet and
Levin, 2013b, 2014). Here, we use this assay to investigate the
interplay between bioelectric controls and gap-junctional con-
nectivity in vivo. Unexpectedly, we found that disruption of
cell:cell communication via H7—a chimeric connexin construct
that is known to inhibit GJC in Xenopus (Paul et al., 1995;
Levin and Mercola, 1998)—is able to suppress tumor forma-
tion. Remarkably, the suppression effect was observed regard-
less of where GJC disruption was occurring (host-wide, within
tumors only, or away from tumors). Indeed, themost pronounced
suppression was recorded for GJC disruption taking place non-
locally to oncogene-expressing cells, revealing a role for distant
cell:cell communication in tumorigenesis. Conversely, enhanced
GJC within tumors or their microenvironment, achieved via the
mis-expression of a constitutively permeable junction-forming
connexin Cx26 (Levin and Mercola, 1998), increased tumor inci-
dence. Together, these data suggest that GJC is a mediator of
both local (within tumors) and long-range (within the microen-
vironment and the host) signaling and that specific patterns of
physiological isolation may be necessary for tumor suppression.
Here we also formulate a mechanistic, quantitative model consis-
tent with these data and with prior work on endogenous left-right
asymmetric voltage gradients, and test key predictions of this
model. Based on these data, we suggest that exploiting the bio-
electrical signaling that occurs through electrical synapses among
somatic cells represents an important target for cancer therapy
that is distinct from the targeting of individual channels.
MATERIALS AND METHODS
ANIMAL HUSBANDRY
X. laevis eggs were fertilized in vitro, and embryos were cul-
tured according to standard protocols (Sive et al., 2000), in 0.1X
Modified Marc’s Ringers (MMR; pH 7.8) with 0.1% Gentamicin.
Xenopus embryos were housed at 14–18◦C and staged according
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to Nieuwkoop and Faber (1967). All experimental procedures
involving the use of animals for experimental purposes were
approved by the Institutional Animal Care and Use Committees
(IACUC) and Tufts University Department of Lab Animal
Medicine (DLAM) under the protocol number M2014-79.
MICROINJECTION
FertilizedXenopus embryos were transferred intomesh-bottomed
dishes with 3% Ficoll and injected with capped, synthetic mRNAs
(made using the AmbionMessageMachine kit) dissolved in water
at the stages indicated. The doses per cell were KRASG12D (Le
et al., 2007), 40 pg; H7 (Paul et al., 1995), 70 pg; Cx26 (Levin and
Mercola, 1998), 500 pg; and β-gal (lineage tracer), 400 pg. Two
hours after injection, embryos were transferred into 0.75X MMR
for 45min before they were washed and cultured in 0.1X MMR
until desired stage was reached.KRASG12D-injected embryos were
raised to stage ∼35, and scored for the presence of tumors
using bright field microscopy as described in Chernet and Levin
(2013b).
TESTING GJC
GJC was assessed between tumors and the host using a 1:1
mixture of Rhodamine-Lysinated Dextran (RLD, 10 kDa,
Life Technologies) and Lucifer Yellow (LY, 0.522 kDa, Life
Technologies) (Figure 1). 16 cell embryos injected with
KRASG12D, RLD, and LY were allowed to grow to stage ∼35. Cells
exhibiting LY signal (which passes through GJs) in the absence
of RLD (which does not pass through GJs) signal reveal an open
gap-junctional communication (cells with both LY and RLD sig-
nal indicate regions that have acquired the twomolecules through
cell division and/or migration). RLD and LY were detected in live
embryos using TRITC and Lucifer Yellow filtersets, respectively,
on an Olympus BX61 spinning-disk confocal microscope with
Hamamatsu ORCA digital CCD camera.
STATISTICAL ANALYSIS
Data were expressed as the mean unless otherwise noted. The dif-
ferences between treatment groups were analyzed using Student’s
t-test and X2 test, and the null hypothesis was rejected at the 0.05
level.
PREDICTIVE MODELING
A quantitative model of embryonic growth and response to
microinjection treatments was developed in two stages that
model different processes (Figures 4, 5). The first-stage “left-
right synchronization” model was implemented using JavaScript
and the HTML5 “canvas” function. Details of this model are
described below (Section A two-stage quantitative model describes
the dynamics between Vmem, GJC, and tumor formation); the
model is interactive, and can be manipulated and the source code
can be examined at http://chrisfieldsresearch.com/convergence-
demo.htm (also seen in Supplement 1). The second-stage “left-
right communication” model comprises the implications of a set
of assumptions that specify a control network as described below
(Section A two-stage quantitative model accurately predicts the
dynamics between Vmem, GJC, and tumor formation). Numerical
predictions were calculated manually from these assumptions.
FIGURE 1 | KRASG12D injection results in the formation of induced
tumor like structures that are gap junctionally connected to the host.
(A) The schematic shows injection of KRASG12D + RLD
(Rhodamine-Lysinated Dextran, M. W. 10 kDa) + LY (M.W. 0.522 kDa) into
one cell of a 16-cell stage embryos. The RLD labels injected cells (and their
descendants), while LY is small enough to traverse gap junctions. (B) At a
stage 34 embryo (white dotted outline), LY signal is present not only in
tissue derived from the injected cell (tumor; green arrowheads) but also
widely throughout the rest of the host. (C) RLD shows cells injected with
oncogene, some of which are in the localized tumors and others that have
migrated (metastasized) out into the host. (D) Overlay of the two signals
reveals areas (white arrowheads) that exhibit LY signal but not RLD signal,
which demarcate cells that are in active GJ communication with the
injected (tumor) cells (N = 5 of 5). Schematic in panel A (and in subsequent
figures) is used with permission from Nieuwkoop and Faber (1967).
RESULTS
KRASG12D-INDUCED TUMORS ARE JUNCTIONALLY COUPLED TO
NORMAL HOST CELLS
To study the role of GJC in oncogene-mediated tumorigenesis,
we made use of a simple assay that utilizes expression of an
exogenous human oncogene in X. laevis embryos (Figure 1A).
This model system is ideal for probing connexin-based GJC
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(Swenson et al., 1989; Barrio et al., 1997; Cao et al., 1998; Lee
et al., 2009) and has been used to study GJC-mediated mor-
phogenesis and large-scale patterning (Warner, 1992; Levin and
Mercola, 1998; Levin, 2002). The oncogene KRASG12D (Le et al.,
2007) was used to induce Xenopus tumors (Figures 1B–D, green
arrowhead). These exhibit the same major hallmarks of tumors
as do their mammalian counterparts: increased mitotic activ-
ity, induced vasculogenesis, disorganization of normal cellular
architecture, increased hypoxia, acidic microenvironment, and
ability to illicit innate immune response (Chernet and Levin,
2013b, 2014). We began by testing GJC between induced tumors
and the host, which revealed considerable spreading of the small
GJC-permeant tracer Lucifer Yellow (Figures 1B,D; yellow sig-
nals, white arrowheads) away from descendants of one of the
16 progeny cells that were injected with oncogene mRNA and a
large, GJC-impermeant Rhodamine Dextran (5 out of 5 tested;
Figures 1C,D; red signal). Having observed active GJC between
the tumor and surrounding host tissue, we began functional stud-
ies by investigating how the growth of these oncogene-induced
tumors is affected by spatially targeted disruption of GJC. All of
the reagents used below were titered to levels low enough that
the normal background processes of embryogenesis and growth
proceeded normally.
DISRUPTION OF GJC REDUCES TUMOR INCIDENCE
To determine the effect of GJC disruption on tumorigenesis
in vivo, mRNAs of dominant-negative connexin H7 (Paul et al.,
1995; Levin and Mercola, 1998) and KRASG12D were injected in
X. laevis embryos. The oncogene and GJC disrupting constructs
were introduced in different spatial arrangements to investigate
what happens when GJC is disrupted host-wide, within tumors,
and away from tumors. Taking advantage of the embryonic fate-
map (Dale and Slack, 1987; Moody and Kline, 1990), we were able
to control which cells received oncogene mRNA and which cells
were inhibited with respect to GJC. To achieve suppression of GJC
within the tumor (“local” mode), H7 mRNA was injected into
1 cell of a 2-cell embryo and the KRASG12D mRNA was intro-
duced into one of the progeny of that cell (at the 16-cell stage).
For remote (“long range” mode) GJC suppression in tissue out-
side the tumor, H7 mRNA was injected into 1 cell of a 2-cell
embryo, which was raised to the 16-cell stage and then injected
with KRASG12D mRNA into one of the cells on the opposite side
of the embryo from the cells bearing the H7. For host-wide GJC
disruption, both of the 2 cells of the 2-cell embryo were injected
with H7, and KRASG12D mRNA was then injected in 1 of the 16
progeny cells. Figure 2 shows the various combinations of which
sides of the embryo received the GJ blocker (H7) and which
received the oncogene (KRASG12D).
Compared to tumor incidences observed in the baseline
KRASG12D-only injected embryos (Figure 2; treatment mode A),
local (treatment mode B) and host-wide (treatment mode D) dis-
ruption of GJC showed significant suppression of tumor forma-
tion by 6.6 and 5.8%, respectively (t-test; p < 0.05). Interestingly,
long-range disruption of GJC (treatment mode C) had the
FIGURE 2 | Selective disruption of gap junctional communication (GJC)
reduced tumor incidence. To determine the effect of GJC disruption on
tumorigenesis, H7 and KRASG12D injections—aimed at disrupting GJC
host-wide, within tumors, and away from tumors—were performed.
Compared to KRASG12D -only injected embryos (treatment mode A),
treatment modes B and D showed significant decrease in % embryos with
tumor by 6.6 and 5.8%, respectively, implying that H7 contralateral to the
oncogene has no effect if there is H7 ipselateral to the oncogene.
Contralateral H7 only (treatment mode C) significantly reduces the %
embryos with tumor by 15.8%. Doubling the level of oncogene injected along
with host-wide introduction of H7 (treatment mode F) does not affect tumor
incidence when compared to oncogene-only (one side) injected embryos
(treatment mode A), but is able to counter the 9.9% increase in tumor
incidence resulting from excess oncogene introduced (treatment mode G)
down to the tumor incidence level of one-side oncogene injection. Similarly,
tumor incidence from the excess oncogene introduction can be reduced by
H7 introduction to either side of the embryo (treatment mode
E). ∗P < 0.05, ∗∗P < 0.001; t-test.
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strongest suppressive effect, showing a 15.8% decrease in the
number of embryos with tumor (t-test; p < 0.001). Injection
of H7 host-wide with KRASG12D injected in 2 cells on oppo-
site sides of the 16-cell embryo (Figure 2; treatment mode F)
did not affect tumor incidence when compared to KRASG12D-
only injected embryos (Figure 2; treatment mode A). However,
the host-wide H7 introduction (Figure 2; treatment mode F)
reduced tumor incidence resulting from oncogene expression on
both sides of the embryo (compare to Figure 2; treatment mode
G) by more than 11% (t-test; p < 0.05). Similarly, tumor inci-
dence from doubling the oncogene level can be reduced by the
introduction of H7 to only one side of the embryo (treatment
mode E). Together, the results imply that GJC disruption sup-
presses KRASG12D-induced tumors: the most pronounced effect
on tumor incidence is observed when H7 is introduced at a dis-
tance from the oncogene-bearing cells, unless H7 is also expressed
within the oncogene-expressing cells, in which case suppression is
not as effective.
FACILITATED GJC PROMOTES TUMOR FORMATION
To further test the hypothesis that GJC plays a role in oncogene-
mediated tumorigenesis, we scored tumor incidence in embryos
injected with Cx26, a short connexin protein which lacks most
of the intracellular regulatory region, and thus facilitates GJC by
forming constitutively permeable gap junctions (Mesnil et al.,
1997; Levin and Mercola, 1998). Similar to the H7 (GJ block-
ade) experiment, mRNA injections of Cx26 and KRASG12D aimed
at enhancing GJC host-wide, within tumors, and away from
tumors were performed (Figure 3). Compared to KRASG12D-
only injected embryos (Figure 3, treatment mode A), long-
range and host-wide Cx26 treatments (treatment modes C,
D, F) both showed an increase in number of embryos with
tumor by 6.4 to 11.4%. This is in contrast to the H7 data
where modulation of long-range GJC had the most impact on
tumor incidence. Interestingly, enhanced GJC within tumors
(treatment modes B and E) slightly (but not significantly)
decreased tumor incidences when compared to treatment modes
A and F, respectively. Together, these data indicate that facil-
itating GJC host-wide and in the tumor microenvironment
enhances the tumorigenesis process. In contrast, enhanced GJC
within oncogene-expressing cells had minimal effect on tumor
formation.
A TWO-STAGE QUANTITATIVE MODEL DESCRIBES THE DYNAMICS
BETWEEN Vmem, GJC, AND TUMOR FORMATION
The tumor-incidence results were challenging to explain for
the following reason. While perturbing GJC in the same side
as KRASG12D expression (Figure 2, treatment mode B) reduced
FIGURE 3 | Enhanced gap junctional communication (GJC) through
connexin 26 (Cx26) overexpression increases tumor incidence. To
determine the effect of GJC disruption on tumorigenesis, Cx26 and
KRASG12D injections—aimed at enhancing GJC host-wide, within
tumors, and away from tumors—were performed. Compared to
KRASG12D -only injected embryos (treatment mode A), long-range and
host-wide Cx26 treatment modes (C, D, F) show an increase in the
number of embryos with tumor by 6.4 to 11.4%. However,
treatments involving the expression of oncogene and Cx26 on the
same side (treatment modes B and E), while non-significant, lower
tumor incidence when compared to treatment modes A and F,
respectively. ∗P < 0.05; t-test.
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tumor incidence, the effect became more pronounced when the
GJC perturbation is on the opposite side of KRASG12D injection
(treatment mode C); it is puzzling why having H7 on the opposite
side from KRASG12D injection could make the KRASG12D express-
ing side much less likely to form a tumor. More strikingly, why
would perturbing GJC on both sides of the embryo, while only
introducing KRASG12D on one side (Figure 2, treatment mode
D), have the same effect as perturbing GJC on the KRASG12D
injected side only?
In order to mechanistically integrate the main components
of our experiments (Vmem manipulated by ion channel injec-
tions, GJC manipulated by Cx injections, and long-range effects
on tumors induced by oncogene injections), a two-stage model
was developed to explain the tumor-incidence data shown in
Figures 2, 3 and to make additional testable predictions. The
first stage of this model (Figure 4) establishes regions of different
Vmem within the embryo and provides the input required by the
second stage (Figure 5), which shows the dynamics that regulate
tumor outcome. The dynamics postulated by the second-stage
model require that the left and right sides of the embryo exchange
a signal; it is assumed that this alternating signal is implemented,
or at least enabled, by coupled oscillations of Vmem on the two
sides as described in more detail below.
Our two-stage model is based on the observation that large-
scale bioelectric cues can provide patterning information during
development (Nuccitelli, 2003a,b; McCaig et al., 2005, 2009;
Levin, 2012a; Zhao et al., 2012). Let us call the left and right
sides of the Xenopus embryo A and B, in no particular order.
Assume that the two sides exchange a long-range signal that con-
trols proper patterning and subsequentmaintenance of order, and
that both A and B also respond to cell-autonomous and local sig-
nals. We hypothesized that it is an interaction between long-range
and short-range signals that produces the non-local effects that
we see.
If the left and right sides of the embryo are to produce a
coherent long-range bioelectric signal, their long-range signaling
activity must be coordinated or synchronized. Cells are known,
for example, to alternate between hyperpolarization and depolar-
ization with cell cycle (Bregestovski et al., 1992; Arcangeli et al.,
1995; Blackiston et al., 2009). If this alternation between hyper-
polarization and depolarization was synchronized so that the
left side was fully polarized when the right side was fully depo-
larized and vice-versa, it could produce a coherent long-range
signal. The first, “left-right synchronization” stage of our model
generates synchronized left and right cell populations from a ran-
dom initial state. The model assumes a total starting population
of 100 cells, corresponding roughly to embryonic cell division
seven (27 = 128). Below this number of cells, nearest-neighbor
interactions are insufficient to produce global order because too
many neighborhoods overlap. The model also assumes an initial
left-right bias in the polarization state of the cells [as has been
observed experimentally to derive from consistently-asymmetric
localization of ion channels on the left and right sides of the 2-cell
embryo as it divides (Levin et al., 2002; Qiu et al., 2005; Adams
et al., 2006; Morokuma et al., 2008)]. The left-right bias was
treated as a free parameter and varied to optimize model behav-
ior. The cells are assumed to occupy a planar array representing
FIGURE 4 | “Left-right synchronization” model for the establishment
(Stage 1) of electrical states that modify long-range
gap-junction-mediated influences on tumorigenesis. The “left-right
synchronization” model shows that stable, bioelectrically-synchronized cell
populations on the left and right sides of the embryo, here represented by
red and blue regions, can be generated from a random initial state by
nearest-neighbor interactions alone. This model is implemented on a fixed
10 × 10 grid with the left and right exterior boundaries mathematically
identified to yield a cylindrical topology. This topology allows the two
synchronized populations to “wrap” around the exterior border. The final
model shown here was obtained by varying the left—right polarization bias
parameter “X” while requiring two stable populations with no ectopic
islands as output. This procedure allowed the value of the left—right
polarization bias to the predicted to be 27%, consistent with observations
(Levin et al., 2002; Adams et al., 2006). While the left-right border is
represented at low resolution in the model and most solutions produce a
straight, sharp boundary, this is not a biologically-meaningful constraint and
the actual border between “left” and “right” cell populations in the embryo
may be irregular as shown. The “left-right communication” model assumes
that the two bioelectrically-synchronized sides exchange a long-range,
oscillatory bioelectric signal; whether this signal requires an additional
trigger for initiation is currently unknown. This model employs a small set of
assumptions to quantitatively predict the tumor incidence expected when
GJC is either suppressed by H7 or enhanced by Cx26. These predictions
are then compared with experimental tumor frequencies (indicated by “?”).
See Figure 5 for additional details of this model.
the embryonic animal cap epithelium. Each cell is assumed to
communicate only with its four nearest neighbors. Each square
of the 10 × 10 array (Figure 4) represents one cell at the 100-cell
stage; as embryonic cells continue to divide, each square repre-
sents the daughter cells in the epithelial “patch” occupied by their
progenitor at the 100-cell stage. The left and right boundaries
of the planar array are mathematically identified (joined) so that
Frontiers in Physiology | Biophysics January 2015 | Volume 5 | Article 519 | 6
Chernet et al. Long-range gap junctional coupling and cancer
FIGURE 5 | The stage-2 “left-right communication” model for the
GJC-mediated effects of Vmem change on incidence of tumorigenesis.
The “left-right communication” model assumes that the left and right sides
of the embryo alternately signal each other to turn the rate of cell division
down (A) using an oscillation between polarization and depolarization as
the long-range bioelectric signal (B). For example, KRASG12D and H7
expressions on opposite sides of the embryo (as shown in Figure 2
treatment C, and sections through a trunk tumor in Panel D) result in an
increase in signaling from the H7-injected side and a consequent
suppression in KRASG12D -induced tumors on the opposite side (C,D). The
stage-2 model can be visualized as a control network that regulates cellular
response to KRASG12D and both the production of ipsilateral signal (IS) and
response to contralateral signal (CS). Here unlabeled flat-end arrows
indicate a 100% suppressing effect (E). In this model, gap junctions are a
central component, contributing to the long-range dynamics by allowing
cells to sense neighbors’ Vmem. Cellular mechanisms corresponding to
these arrows are not yet fully characterized; however, the
butyrate—histone deacetylase pathway previously characterized in these
embryos (Chernet and Levin, 2013a,b, 2014); is a plausible candidate for
transducing the global bioelectrical signal into a local cellular response to
KRASG12D transformation.
neighborhoods “wrap” around this boundary; the 10 × 10 planar
array thus has the topology of a cylinder. Making the upper and
lower boundaries join also, to form a spherical topology, was
found to have no significant effect on the model’s behavior.
The initial random state of the 10 × 10 array was generated by
assigning each square of the array two independent integer values:
a random “polarization” value between 0 and 255 and a random
“depolarization” value between 0 and 255. These random values
were then biased by adding a single bias value both to the random
“polarization” values of the squares on the left side of the grid
and to the random “depolarization” values of the squares on the
right side of the grid. At the 100-cell stage, these distinct values
represent the potentially-distinct polarization values of distinct
cell-membrane patches within a single cell (Wallace, 2007; Adams
and Levin, 2013); their sum represents the average Vmem of
that cell. Following the 100-cell stage, these distinct values also
represent the potentially-distinct polarization values of distinct
daughter cells within an epithelial patch; their sum represents
the average Vmem of that patch. The JavaScript Math.random
function was used to generate random values. Cell behavior was
modeled by a single local rule uniformly implemented by all
squares of the array. On each cycle, each square computed the
ratio between the total polarization and depolarization values
of its four neighbors. If the ratio was greater than or equal to 1,
the square multiplied its own polarization value by 1.2 and its
own depolarization value by 0.8; if the ratio was less than 1, it
did the opposite. These multipliers represent the local response
of cells to the average bioelectric state of neighboring cells; cells
surrounded by polarized cells become more polarized, while
cells surrounded by depolarized cells become less polarized. The
values of 1.2 and 0.8 were chosen to produce convergence to a
stable state within less than 50 cycles on most model runs; small
variations in the values of these multipliers had no significant
effect on the qualitative behavior of the model.
This first stage of the model represents the dynamics of bio-
electric state change in the early embryo. Its prediction that
nearest-neighbor interactions are sufficient to drive convergence
to a stable bioelectric state is borne out by timelapse videos using
voltage-sensitive fluorescent dyes (Adams and Levin, 2012) in
Xenopus embryos, which reveal precisely this kind of fluctuation
that then settles on a consistent difference in resting potential.
Interestingly, the model shows that despite considerable stochas-
tic variability in individual cells’ states, such a system consistently
converges to a stable state in which the embryo exhibits large
regions of identical voltage. In this way, this model for the first
time provides an explanation for the observed robustness of bio-
electric patterns in development despite the known physiological
noise (variability) in individual cells’ states.
The model was run until all squares had converged to either
fully polarized, defined as a “polarization” value of at least 230
and a “depolarization” value of at most 15, or fully depolarized,
defined with the reverse criteria. Replicate model runs that dif-
fered only in their initial random states were evaluated on the
basis of two criteria: whether the fraction of either polarized or
depolarized cells was greater than 65%, and whether more than
one region, accounting for “wraps” around the mathematically-
identified left and right boundaries, in each state existed, i.e.,
whether there were “ectopic islands” of polarized or depolarized
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cells. Due to the model’s cylindrical topology, regions of one
color, representing one polarization, sometimes “wrap” around
the mathematically-identified left and right boundaries, i.e., blue
squares appear on the left border and/or red squares appear on
the right border. A region was considered “ectopic” only if it com-
prised one or more squares completely surrounded by squares of
the opposite color, or surrounded by squares of the opposite color
on three sides if the remaining side formed part of the top or bot-
tom border. The requirement that the number of solutions failing
to satisfy either of these criteria is negligible (< 3%) in 100 con-
secutive runs yields a value of 27% for the initial, 1st-division
bias in Vmem among the left and right side blastomeres. This
prediction of the model is in accordance with data, since direct
measurements of voltage states in early embryos, as well as pro-
tein and mRNA analyses show consistent and significant biases in
the bioelectric states of 2- or 4-cell frog embryos. Decreasing the
percent adjustment in polarization and depolarization values on
each cycle downward from 20% increases the convergence time
for this model without qualitatively changing the results, as does
running the model on a 20 × 20 grid (i.e., 400 squares total).
THE TWO-STAGE QUANTITATIVE MODEL ACCURATELY PREDICTS THE
DYNAMIC BETWEEN Vmem, GJC, AND TUMOR FORMATION
The existence of bioelectrically-synchronized cell populations on
the left and right sides of the embryo that is predicted by the
stage-1 model is used by the stage-2, “left-right communication”
model to explain the observed results of combining KRASG12D
with either H7 or Cx26 (Figure 2). Experimental data show that
35% of KRASG12D-injected embryos produced tumors; compare
this to 44% tumor incidence in embryos injected with KRASG12D
on both sides (Figure 2). The non-linearity of tumor incidence
by itself is an indication of growth control as a result of cross-talk
(i.e., a contralateral signal) between sides A and B. Our stage-2
model is based on two primary assumptions. First, we propose
that the Vmem values of the cells on the left and right sides of
the embryo oscillate, in synchrony, with cells on the left polariz-
ing when cells on the right depolarize and vice-versa as discussed
above. Normal, non-tumor cells respond to the long-range, syn-
chronized, oscillatory bioelectric signal produced by the con-
tralateral side of the embryo (i.e., to the contralateral signal), but
not to the long-range signal that they themselves produce (i.e.,
the ipsilateral signal). We conceptualize this contralateral signal
as a cell-division suppressor; the A and B sides of the embryo
are, on this model, alternately signaling to the other side of the
embryo to turn the rate of cell division down (Figure 5A), thus
maintaining approximate equality of cell-division rates on the
two sides. Increased (decreased) contralateral signal is assumed
to decrease (increase) tumor formation probability on a % for
% basis. Second, we propose that disrupting wild-type GJ with
either H7 or Cx26 alters both production of and response to the
long-range signal. In particular, we assume that the expression
of a dominant negative H7 disrupts response to the contralateral
signal (Figures 5C,D) on that side in two ways, by blocking the
% for % tumor-suppressing capability of increased contralateral
signal, and by causing cells in that same region to increase pro-
duction of their own (ipsilateral) signal by 50%. We assume the
presence of tumor cells on either side disables the increased signal
production on that side. The model also requires that tumor cells,
but not normal cells, on the contralateral side respond to this
increased signal by further suppressing cell division; otherwise the
division of normal cells would be over-suppressed. This restric-
tion corresponds biologically to a response saturation on the part
of normal cells that is disabled in tumor cells. We model Cx26
as having the opposite effect of increasing response to contralat-
eral signal and decreasing production of ipsilateral signal. We also
assume that local disruption of GJC by H7 decreases KRASG12D
tumor incidence by 20%, while local enhancement of GJC by
Cx26 increases tumor incidence by 20%; these local effects are
insensitive to contralateral signal.
With these assumptions, it is straightforward to calculate the
results expected from the experimental manipulations shown in
Figures 2, 3. A single injection of KRASG12D on one side of the
embryo produces 35% tumors (Figures 2, 3, treatment mode
A); this baseline number provides the starting point for calcula-
tions. An ipsilateral H7 background decreases cellular response to
KRASG12D by 20%; hence the expected tumor incidence following
Figure 2, treatment mode B is 80% of 35%, i.e., 28%, a prediction
error of only 0.3% compared to the observed value (Figure 6A,
treatment mode B). The more interesting case is a contralat-
eral H7 background (treatment mode C). Here contralateral H7
causes the contralateral cells to increase signal production by
50%; intuitively, the contralateral cells cannot perceive the sig-
nal produced by their neighbors due to disruption of GJC by
H7, so they turn up their own signal production to compensate.
The KRASG12D-ipsilateral side, therefore, receives 50%more con-
tralateral signal. Increased contralateral signal turns KRASG12D
response down on a % for % basis, so the expected tumor inci-
dence following Figure 2, treatment mode C is 50% of 35%, i.e.,
17.5%, a prediction error of 2.2% compared to the observed
value. In treatment mode D, both sides of the embryo have an
H7 background. Signal production is increased on the side con-
tralateral to KRASG12D, but the tumor-suppressing capability of
this increased contralateral signal is disrupted by the ipsilateral
H7. The situation is, therefore, the same as in treatment mode A;
KRASG12D activity is only decreased by 20% due to the ipsilateral
H7 background. This prediction of 28% tumors has a prediction
error of only 1.2% (Figure 6A, treatment mode D). Treatment
modes E and F both involve KRASG12D injections on both sides of
the embryo; here the 44.9% tumor incidence observed with treat-
ment mode G is used as the baseline, i.e., a baseline of 22.45%
tumors is assumed on each of the two sides. With KRASG12D
present on both sides, neither side can increase signal produc-
tion in response to H7. In treatment mode E, H7 is present on
one side, so the predicted tumor incidence is 20% less on that
side only; hence the total predicted incidence is (80 × 22.45%) +
22.45% = 40.4%, a prediction error of 1.7%. In treatment mode
F, H7 provides 20% tumor suppression on both sides, so the total
predicted incidence is (80 × 22.45%) × 2 = 35.9%, a prediction
error of 2.2% compared to observations (Figure 6A, treatment
mode F). The predictions for Cx26 backgrounds are performed
similarly (Figure 6B).
The model assumptions used here effectively specify a control
structure (Figure 5E). Each arrow in this structure represents a
cellular process regulating response toKRASG12D, H7, or Cx26. To
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FIGURE 6 | Predicted tumor incidences that match those of experimental
data under GJC perturbations were derived from the stage-2 “left-right
communication” model. In predicting tumor incidences, the left-right
communication model implements the following assumptions about cellular
responses to KRASG12D and H7 (A). Assumption 1: embryos have two sides,
A and B. During normal embryonic development, sides A and B exchange a
handshaking signal that limits cell division. Each side responds to the other
side’s (i.e. contralateral) signal but not to its own (ipsilateral) signal. A
moderately increased or decreased signal is not detrimental to the normal
development of unperturbed embryos. Assumption 2: experimental data
showed 35% of KRASG12D -injected embryos produce tumors. KRASG12D
injections on opposite sides of 16-cell embryos results in 44.9% tumor
incidence. The 44% incidence is evenly split between two sides (22.45%
incidence per injected side). Assumption 3: H7 makes cells deaf to the
contralateral signal; in response, they increase production of their own
ipsilateral signal, by 50%. Assumption 4: Increased (decreased) contralateral
signal suppresses (enhances) KRASG12D activity on a % for % basis. Ipsilateral
H7 directly suppresses oncogenic transformation of KRASG12D expressing
cells by 20%; contralateral H7 has no direct effect. Assumption 5: KRASG12D
expressing cells disable the increase in signal generation ipsilaterally by
interfering with KRASG12D -ipsilateral side bioelectric synchronization. Taking
into account these five assumptions, the predicted tumor values were
calculated for each treatment mode and compared to the observed tumor
incidence. The model accurately predicts tumor incidence for every oncogene
combination. The stage-2 “left-right communication” model implements the
following assumptions about cellular responses to KRASG12D and Cx26 to
account for enhanced (as opposed to disrupted) GJC (B). Assumptions 1 and
2 of the model remain the same as stated in panel (A). Assumption 3: Cx26
enhances cells’ exposure the contralateral signal; in response, they decrease
production of their own ipsilateral signal, by 50%. Assumption4: Increased
(decreased) contralateral signal suppresses (enhances) KRASG12D activity on a
% for % basis. Ipsilateral Cx26 directly increases oncogenic transformation of
KRASG12D cells by 20%; Contralateral Cx26 has no direct effect. While the
model predicts the general trend of increased tumorigenesis as a result of
enhanced GJC, saturation of tumor incidence around 46% is observed,
resulting in higher predictive than actual values.
objectively test the apparent ability of the model to correctly pre-
dict the observed data (Figures 2, 3), we performed a chi-squared
test between the model’s predicted outcomes (“expected”) and
the actual data (“observed”) for the various experimental setups.
For the H7 injections, X2 = 0.547 (df = 4), p = 0.97, while for
the Cx26 injections,X2 = 5.264 (df = 4), p = 0.26, thus showing
no significant difference between the model’s predictions and the
experimental data. We conclude that the emergent dynamics of
this quantitative model accurately reproduce the complex exper-
imental dataset linking GJC, Vmem control, and resulting tumor
incidence in various spatial configurations.
EXPERIMENTAL CONFIRMATION OF A NOVEL PREDICTION OF THE
MODEL: DIFFERENT OUTCOMES OF REAGENT PLACEMENT ALONG THE
LEFT-RIGHT vs. DORSO-VENTRAL AXES
We next tested a novel, surprising prediction of this model that
would not have been made without it (by inspection of the exper-
imental data alone): that effectiveness of ion channel injections
on tumor suppression will be different depending on which
embryonic axis is used to separate the sites of injection.
If two neighboring populations of cells are alternating between
polarization and depolarization with opposite phase, so that
A-side cells are polarized when B-side cells are depolarized and
vice-versa, then the cells forming the border between the two
populations must maintain a polarization value very near the
average for the two populations. These cells, which form the
borders between red and blue in Figure 4 can, therefore, be
expected to have qualitatively different behavior from cells away
from these borders. Therefore, the model also predicts that the
ability of GJC reagents to alter the incidence of tumorigenesis
should be different depending on whether the opposite sides of
the oncogene/H7 axis are oriented with respect to the left-right
or dorso-ventral embryonic axes, since the left-right (LR) axis is
the one along which gradients of resting potential are known to
exist (Levin et al., 2002; Aw et al., 2008). We tested this prediction
(Figure 7), and found that indeed the GJC state is most relevant
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FIGURE 7 | Testing a unique prediction of our model: tumor incidence
is affected by long-range signaling across the left-right axis but not
across the dorso-ventral axis. (A) (i) Embryos were injected with H7 and
KRASG12D , separately and randomly, in the dorsal and ventral blastomeres.
(ii) Embryos were also injected with H7 and KRASG12D in the left and right
blastomeres, or vise versa. Control embryos injected with KRASG12D only
displayed a 35% tumor incidence. (B) Compared to controls, embryos
injected with KRASG12D and H7 across the dorsoventral axis did not show a
change in tumor incidence (32.4%). Whereas perturbation of GJC
communication across the left-right axis significantly lowered tumor
incidence down to 20.5% (∗P < 0.05, X 2 test).
when the opposite-sided distribution of H7-oncogene mRNA
coincides with the early embryo’s left-right axis. This stage-1
model thus makes unexpected predictions that are supported by
experimental test.
DISCUSSION
GJ CONNECTIVITY AS A MODULATOR OF VOLTAGE-DEPENDENCE OF
TUMOR INDUCTION
We examined the role of GJC in oncogene-mediated tumorigen-
esis in Xenopus embryos by targeted molecular-genetic modula-
tion. Injection of mRNA constructs that modify gap junctional
states in Xenopus significantly affected the incidence of tumori-
genesis, as detected by increases or decreases in tumor formation
after oncogene expression (although the absolute magnitude of
the effect of GJ-targeting reagents was limited by the need to
use low doses of mRNA to avoid disrupting normal develop-
ment). Reasonably, the reagent that disrupts GJC and the one
that enhances GJC affect tumor incidence in opposite directions.
However, we were surprised to see that abrogation of GJC actually
suppressed the effects of oncogenes, in contrast to prior sugges-
tions that loss of GJC was a hallmark of incipient cancer (Vine
and Bertram, 2002; Sirnes et al., 2012). Interestingly, in addition
to confirming in vivo the cell-autonomous role inferred for GJCs
by cell culture and clinical test data, we found that the greatest
impact on tumor incidence occurs when we alter the GJC of cells
far away from the tumor. While the microenvironment is increas-
ingly seen to play an important role in cancer (Kenny and Bissell,
2003; Maffini et al., 2005; Hendrix et al., 2007; Kenny et al., 2007;
Kasemeier-Kulesa et al., 2008; Tarin, 2012), long-range develop-
mental signals are not yet widely addressed. It should be noted
however that two very early workers in the bioelectricity of can-
cer had previously suggested that such a long-range effect should
exist (Burr et al., 1938, 1940; Burr, 1941; Nordenström, 1983).
Targeted expression of wild type connexin Cx26 and dominant
negative connexin H7 allowed us to probe how cell:cell communi-
cation affects KRASG12D activity. Induction of GJC host-wide or
non-local to KRASG12D-expressing cells led to increases in tumor
incidence. Enhanced GJC within KRASG12D-expressing cells did
not affect tumor incidence. While the increases in tumor inci-
dence seen as a result of GJC induction by Cx26 are significant,
the impact of GJC on tumorigenesis was less than expected, partly
due to the non-linearity in dose dependence of KRASG12D tumor
formation. We demonstrated this non-linearity in dose depen-
dence by showing that doubling KRASG12D only increases tumor
incidence by 9%. Conversely, inhibition of GJC by the dominant
negative H7 led to tumor suppression regardless of where H7 was
introduced. Both local and host-wide GJC significantly reduced
tumor incidence, and long-range disruption of GJC had the most
impact on tumor incidence, resulting in 15.8% less embryos
with tumor. These results suggest that oncogene-expressing cells
utilize the network of GJs between tumors and healthy tissue
(Figure 1) to drive tumorigenesis. Most importantly, these data
suggest treatment strategies in which oncogene-expressing cells
can be junctionally isolated in order to counteract neoplastic
transformation.
In contrast to these results, there are significant clinical data
implicating GJC as a carcinogenesis suppressor because of its
ability to mediate growth control, and that disturbance of GJC
between cells is a characteristic of several cancers (Yamasaki, 1990;
Rose et al., 1993; Grossman et al., 1994; Hirschi et al., 1996;
Yamasaki et al., 1999). However, some tumor cells have been
shown to increase expression of functional connexin upon leav-
ing their primary growth sites (Kamibayashi et al., 1995; Zhang
et al., 1999). For example, melanoma cells have low levels of Cx26
expression when residing in the epidermal basal layer. However,
upon acquiring sustained growth capability, they detach from the
epidermis and up-regulate Cx26 expression, which is thought to
help them couple with endothelial cells and infiltrate secondary
sites (Ito et al., 2000). Overall, the studies presented here high-
light scenarios in which enhanced GJC is favorable to tumors and
detrimental to the host.
A QUANTITATIVE MODEL INTEGRATING GJ, VOLTAGE, AND
ANATOMICAL AXES IN TUMORIGENESIS
The results presented here revealed that blocking GJC sup-
pressed tumor formation, while promoting GJC enhanced tumor
formation. Even more remarkable was the spatial range over
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which tumorigenesis could be affected: modulation of GJC at
the maximal possible distance from oncogene expressing cells
had the most impact on tumor incidence, suggesting a long-
range morphogenetic signal that controls tumor growth. In order
to formulate a model that quantitatively predicts and explains
this puzzling dataset, we undertook a mechanistic/mathematical
approach featuring a reasonable set of assumptions.
We propose that H7 disrupts the coordination of polarization-
depolarization cycles on the affected side and makes the volt-
age swings on the affected side bigger; a bigger detected swing
suppresses tumor formation on the contralateral side, pos-
sibly by affecting the activity of Vmem dependent channels.
Enhancing GJC with Cx26, in contrast, may disrupt the sta-
bility of the boundary separating polarized and depolarized
domains. In other words, altering local cell-cell synchrony with
GJC-altering reagents may prevent cells from responding in a
coordinated way to changes in the polarization states of both
their near and distant neighbors, and hence disrupt the oscil-
lating “breathing” pattern required for normal control of cell
proliferation. This can be attributed to the disruption of multi-
cellular physiological networks established by electrical cou-
pling of gap-junctionally connected cells. One of the interesting
aspects of this kind of dynamics is that it is eminently suit-
able for integration of complex decision-making as would be
needed for developmental patterning; for example, the ability
of plasmodium organisms to optimize food gathering strategies
is currently thought to be implemented by information pro-
cessing that arises from the integration of oscillatory patterns
(Tsuda et al., 2009).
While we do not at this time know the molecular nature of
the two signals that implement these dynamics, butyrate and
serotonin are good candidates, given previous data on the role
of these small signaling molecules in long-range bioelectrical
events that regulate cancer (Blackiston et al., 2011; Lobikin et al.,
2012; Chernet and Levin, 2013b, 2014). We propose that gap
junctions function in this process by regulating ion flow that
synchronizes distant cells, enabling global oscillation—the peri-
odic change in the overall electric field within the embryo that
provides long-range information exchange. Our model is able to
quantitatively account for this surprising dataset and tomake new
predictions that were verified by experiment. Subsequent work
will experimentally test additional predictions of the model. In
addition to its implications for control of tumorigenesis, the first
phase of the model (establishment of consistent LR gradient from
stochastic and highly variable initial Vmem cell states) has sig-
nificant implications for the problem of left-right patterning. If
correct, it suggests that the focus of new experiments and the-
ory should be not on stable voltage differences arising directly
and immediately from early ion channel localization at 4-cell
stage, but on understanding the output of a biased dynamical sys-
tem operating at 128-cell to blastula stages. It is also significant
that our model makes experimentally-verified predictions which
functionally link left-right asymmetry and cancer. While con-
nections between these two disparate-seeming fields have been
suggested previously (McManus, 1992; Sandson et al., 1992; Wan
et al., 2011; Wilting and Hagedorn, 2011; Sauer and Klar, 2012;
Veltmaat et al., 2013), this is the first quantitative model of the
FIGURE 8 | Long-range signaling in the frog embryo.
Oncogene-expressing cells (red, Xrel3-tdTomato) are prevented from
forming tumors by hyperpolarizing channel-expressing cells (Kv 1.5-β-gal)
located at a distance. Compare (A) without to (B) with Xrel3-tdTomato. The
∼4mm distance from the center of the tdTomato signal to the farthest
point on the tail expressing β-gal was estimated to be ∼300 cell diameter
(average single cell diameter of 13.3μm).
molecular mechanisms by which these different aspects of pattern
regulation are unified.
CONCLUSION AND PERSPECTIVE
Taken together, our data suggest a complex cross-talk between
distant regions of the body that impinge on the stochastic nature
of tumorigenesis and physiological dynamics. Additional param-
eters related to gap junction density include properties such as
tissue stiffness, which is known to influence cancer cell behav-
ior and alter cell responses to genetic and epigenetic signals
(Bizzarri and Cucina, 2014; Pisanu et al., 2014). Future work
will integrate these factors into ever more comprehensive mod-
els of tumor formation. While the frog embryo is not considered
large by the standards of human medicine (long-range signal-
ing occurs on a scale of from 1.3 to at least 4mm), it represents
about 300 cell diameters (a unit of cell diameter = 13.3μm)—
distinctly non-cell-autonomous (Figure 8). Subsequent work will
mechanistically test other predictions of our model, by tracking
real-time bioelectrical communication through GJs during tumor
induction (a technically very challenging task at the edge of cur-
rent capability). Our data suggest specific tests of this type of
signaling in a mammalian model, and imply that biomedical can-
cer strategies must consider not only the events of the tumor itself
and its microenvironment, but perhaps also signals moving to
and from quite remote tissues in the body.
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